InvestorsHub Logo
Followers 2
Posts 2974
Boards Moderated 0
Alias Born 06/23/2017

Re: EichKing post# 8149

Sunday, 11/12/2017 7:27:53 PM

Sunday, November 12, 2017 7:27:53 PM

Post# of 44784
Thanks EichKing,

People seem to forget our biggest study is 20 people for our phase 1/2 in hip fracture. We have NO evidence with any substantial numbers with humans. You can enjoy phase 3 trials starting, but in essence, they are with phase 2 numbers. Our results in the first actual study with some significant numbers will only come from the IC trial early next year.

So until we get those numbers from 172 subjects from I/C, we are in limbo imo. So until those numbers are released, we really are just a phase 2 at most, company when it comes to all else aside from ARS trial. Maybe that's the reason our price is where we are at. Just thought of that this evening unfortunately. Each phase eliminates a vast proportion of candidates, so until we get those results early next year, we will remain so. Unless ARS kicks in.